reSee.it - Related Video Feed

Dr. Peter McCullough is an internist, cardiologist, and epidemiologist with extensive experience in cardiovascular medicine, having published over 650 papers. He became heavily involved in COVID-19 research early in the pandemic, expressing frustration at the lack of focus on early treatment for patients. He noted that many doctors were gripped by fear and focused on personal protective equipment rather than treating sick patients. McCullough collaborated with international colleagues to develop early treatment protocols, leading to the publication of a paper in August 2020 that outlined a multidrug regimen for treating COVID-19. He criticized the response to COVID-19, highlighting the suppression of effective treatments like hydroxychloroquine and ivermectin, which he believed could have saved many lives. He pointed out that the FDA and CDC failed to provide timely updates on treatment efficacy and safety. He discussed the politicization of hydroxychloroquine, suggesting that its association with former President Trump led to its demonization. McCullough emphasized the importance of early treatment and criticized the focus on vaccination as the sole solution to the pandemic. He argued that the emergency use authorization for vaccines was contingent on the absence of effective treatments, which he believed was a flawed approach. McCullough also addressed the issue of vaccine safety, citing reports of myocarditis and other adverse effects, particularly in young males. He expressed concern over the lack of transparency regarding vaccine risks and the pressure on individuals to get vaccinated without adequate information about potential side effects. He highlighted the importance of natural immunity, asserting that individuals who have recovered from COVID-19 should not be mandated to receive the vaccine. McCullough called for a more balanced discussion about vaccine efficacy and safety, advocating for informed consent and the right to choose treatment options. In conclusion, McCullough urged for a focus on early treatment protocols and transparency regarding vaccine safety, emphasizing that the current approach to managing COVID-19 has led to unnecessary suffering and death. He remains committed to advocating for patients and providing accurate information about COVID-19 treatment and prevention.

Dr. McCullough discusses his early treatment approach for high‑risk COVID-19 patients, detailing the development of outpatient protocols that aimed to prevent hospitalization and death by treating patients at home with oxygen, nutraceuticals, and medications. He traces the evolution of these protocols from hydroxychloroquine and antibiotics to ivermectin, corticosteroids, colchicine, and antithrombotics, emphasizing the importance of early intervention before severe illness sets in. He asserts that the McCullough protocol reduced hospitalizations and cites his public testimony and subsequent publications as evidence of its impact. He then shifts to a broader critique of the pandemic response, arguing that a powerful, well-funded network of organizations and funders coordinated to advance mass vaccination and public health strategies, sometimes at odds with independent medical voices. He attributes much of this to a “biopharmaceutical complex” and describes CEPI, the Gates Foundation, and other actors as drivers behind plans for future pandemics and perpetual vaccine development, including a claimed plan to use vaccines as a primary tool in pandemic response. He discusses Event 201 and SPARS as anticipatory exercises, suggesting that certain pharmaceutical and public health decisions were premeditated rather than spontaneous, and he questions the transparency of data, oversight, and safety reviews. He critiques the regulatory and advocacy landscape, arguing that liability protections, performance incentives, and industry lobbying shaped policy, sometimes at the expense of open scientific discussion about adverse events and long‑term vaccine effects. He also shares his views on vaccine safety monitoring, VAERS data, and the alleged underreporting of deaths, presenting calculations to illustrate the scale of vaccine‑related harms. The conversation then delves into alternative strategies, including detoxification approaches for spike protein, testing for spike antibodies, and the role of natural products, dietary measures, and specialized clinics in mitigating post-vaccination symptoms. Throughout, the host and guest wrestle with trust in institutions, the politics of health care, and the personal responsibility individuals can exercise in managing health outcomes while navigating a highly contested information environment.